This is essential reading for any of my colleagues seeking to understand the real causes of the current middle-east situation and the worldwide impact of October 7th.

Disrupting our assumptions: Reduced kidney function per se should not be a reason to disregard higher NT-proBNP levels: Natriuretic peptides, kidney function and clinical outcomes in HFpEF @jaccjournals #JACCHF jacc.org/doi/10.1016/j.…

If you enjoyed the review earlier this month on barriers & facilitators in remote exercise programs, don't miss this article by Dr. Elad et al. as they discuss factors which facilitate participation in a specific digital home-based CR program. bit.ly/424jH0dv Oren Caspi 🎗️

Very exciting AHA Science in Circ: Heart Failure !! Modeling #HFpEF Using Human Induced Pluripotent Stem Cell–Derived Cardiac Organoids doi.org/10.1161/CIRCHE… A novel, human, in vitro model for HFpEF which "faithfully recapitulated the structural, functional, & mechanistic features of

.Oren Caspi 🎗️'s team established a novel, human, in vitro model for #HeartFailure with preserved ejection fraction (HFpEF). The model recapitulated the structural, functional, and mechanistic features of #HFpEF. 💡 Discover the model: bit.ly/3EjxXsf

🫀 Human cardiac organoids are complex, self-organizing 3D tissues that recapitulate human physiology. Check out these studies by Idan Refael Haim, Oren Caspi 🎗️, Aleksandra Kostina, Aitor Aguirre, & others in Circ: Heart Failure, Cell Proliferation, CDD press, & StemCellReports.

Modeling Heart Failure with Preserved Ejection Fraction Using Human Induced Pluripotent Stem Cell–Derived Cardiac Organoids @MDCASPI Idan Refael Haim gruberamit Technion Israel רמב''ם הקריה הרפואית לבריאות האדם #AHAJournals ahajrnls.org/4gmkxZO

Danish study explores #HeartFailure care disparities: 🔸 55,918 pts, mostly native Danish 🔸 Non-Western immigrant patients: younger, more diabetes & #ischemicheartdisease, less #AFib 🔸 Similar #GDMT uptitration at 12 months 📎: jacc.org/doi/10.1016/j.… #JACCHF #HealthDisparities

It’s exciting to discuss how we can support translational science 🔬with the #HFABasicandTranslational Committee - lots of exciting initiatives to come! ❤️🫀#HeartFailure2025 Ambre Barthélémy Aránzazu González Miqueo Dana Dawson EdoardoBertero Inês Falcão-Pires Alessandra Ghigo

🎉 We are thrilled to share some wonderful news! The study that was presented during the LBCT— and conducted at the Institute of Heart Diseases — has just been published in the EJHF A huge congratulations to the entire research team👏📚 onlinelibrary.wiley.com/doi/10.1002/ej…

The European Society of Cardiology Working Group on Cardiovascular Regenerative and Reparative Medicine. We are proud to introduce the Nucleus team: Monika Gladka Marie-Noelle Giraud MASSIMILIANO GNECCHI, MD, PhD, FESC Sveva.Bio Christian Bär Maurizio Pesce Oren Caspi 🎗️ Ricardo Sanz-Ruiz

Congratulations and gratitude to the #JACC:HF editorial board, contributors, reviewers, staff. Proud to report that our IF is the highest among HF journals,ranks us among the top 10 CV journals! Akshay Desai Shelley Zieroth Minnow Walsh, MD, MACC Anita Deswal Paul Heidenreich Sean Pinney

🚨 New publication from our team at Rambam HF: Weekly ambulatory IV diuresis offers a safe, effective alternative to hospitalization for advanced The analysis based on the DEA-HF study shows significant decongestion across all markers — without compromising safety #CardioTwitter

From concept to clinic: CRISPR/Cas9 gene editing now being applied to in vivo knockout of the TTR gene for ATTR cardiomyopathy - for the first time in Israel. A milestone in translating genome editing into cardiovascular therapeutics. with Dr Ronnie Abbo 🔗 globes.co.il/news/article.a…

ביחידה לאי ספיקת לב ברמב"ם 🏥 ובמרכז המחקר והחדשנות 💡 אנחנו פועלים להפוך את עתיד הקרדיולוגיה ואי ספיקת הלב למציאות עבור המטופלים שלנו. צוות מופלא - ד"ר סירוש פצ'רסקי, ד"ר רוני עבו Dr Ronnie Abbo, ד"ר אינה ווליס ומילה הלמר מוביל אופק חדש ומרתק למטופלים עם Amyloidosis מסוג TTR .